Division of Inflammation and Infection, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
Division of Molecular Medicine and Virology, Department of Biomedical and Clinical Sciences, Wallenberg Centre for Molecular Medicine, Linköping University, Linköping, Sweden.
Pediatr Allergy Immunol. 2020 Jul;31(5):544-553. doi: 10.1111/pai.13240. Epub 2020 Apr 3.
Perinatal childhood exposures, including probiotic supplementation, may affect epigenetic modifications and impact on immune maturation and allergy development. The aim of this study was to assess the effects of pre- and postnatal Lactobacillus reuteri supplementation on DNA methylation in relation to immune maturation and allergy development.
DNA methylation patterns were investigated for allergy-related T helper subsets using a locus-specific method and at a genome-wide scale using the Illumina 450K array. From a randomised, double-blind, placebo-controlled allergy prevention trial with pre- and postnatal probiotic supplementation, CD4+ T helper cells were obtained at birth (from cord blood), and 12 and 24 months of age (total (placebo/probiotics); locus-specific method: CB = 32 (17/15), 12 months = 24 (9/15), 24 months = 35 (15/20); Illumina: CB = 19 (10/9), 12 months = 10 (6/4), 24 months = 19(11/8)).
Comparing probiotics to placebo, the greatest genome-wide differential DNA methylation was observed at birth, where the majority of sites were hypomethylated, indicating transcriptional accessibility in the probiotic group. Bioinformatic analyses, including network analyses, revealed a module containing 91 genes, enriched for immune-related pathways such as chemotaxis, PI3K-Akt, MAPK and TGF-β signalling. A majority of the module genes were associated with atopic manifestations (OR = 1.43, P = 2.4 × 10 ), and a classifier built on this model could predict allergy development (AUC = 0.78, P = 3.0 × 10 ). Pathways such as IFN-γ signalling and T-cell activation were more hypermethylated at birth compared with later in life in both intervention groups over time, in line with DNA methylation patterns in the IFNG locus obtained by the locus-specific methodology.
Maternal L. reuteri supplementation during pregnancy alters DNA methylation patterns in CD4+ T cells towards enhanced immune activation at birth, which may affect immune maturation and allergy development.
围产期儿童暴露于益生菌补充剂等因素可能会影响表观遗传修饰,并影响免疫成熟和过敏发展。本研究旨在评估产前和产后补充罗伊氏乳杆菌对与过敏相关的 T 辅助细胞亚群的 DNA 甲基化的影响,以及其与免疫成熟和过敏发展的关系。
采用特定基因座的方法和 Illumina 450K 芯片对与过敏相关的 T 辅助细胞亚群的 DNA 甲基化模式进行了研究。该研究是一项随机、双盲、安慰剂对照的过敏预防试验,对孕妇进行了产前益生菌补充,并对婴儿进行了产后益生菌补充。从该试验中获得 CD4+T 辅助细胞,分别在出生时(脐血)、12 个月和 24 个月时(总共有(安慰剂/益生菌);特定基因座方法:CB=32(17/15)、12 个月=24(9/15)、24 个月=35(15/20);Illumina:CB=19(10/9)、12 个月=10(6/4)、24 个月=19(11/8))。
与安慰剂相比,益生菌组在出生时观察到最大的全基因组差异 DNA 甲基化,大多数基因座呈低甲基化状态,表明在益生菌组中转录具有可及性。包括网络分析在内的生物信息学分析揭示了一个包含 91 个基因的模块,该模块富含趋化、PI3K-Akt、MAPK 和 TGF-β 信号等免疫相关途径。该模块中的大多数基因与特应性表现相关(OR=1.43,P=2.4×10),并且基于该模型构建的分类器可以预测过敏发展(AUC=0.78,P=3.0×10)。在这两个干预组中,IFN-γ 信号通路和 T 细胞激活等通路的 DNA 甲基化在出生时比生命后期更为超甲基化,这与通过特定基因座方法获得的 IFNG 基因座中的 DNA 甲基化模式一致。
孕妇在妊娠期间补充罗伊氏乳杆菌会改变 CD4+T 细胞的 DNA 甲基化模式,使出生时的免疫激活增强,这可能会影响免疫成熟和过敏发展。